AbbVie Inc.
ABBV · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $188 | $941 | $1,289 | $4,286 |
| Dep. & Amort. | $2,063 | $2,050 | $2,039 | $2,102 |
| Deferred Tax | $193 | -$272 | -$28 | -$767 |
| Stock-Based Comp. | $209 | $179 | $410 | $674 |
| Change in WC | $3,142 | -$562 | -$2,580 | -$397 |
| Other Non-Cash | $1,229 | $2,817 | $505 | $1,150 |
| Operating Cash Flow | $7,024 | $5,153 | $1,635 | $7,048 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $504 | -$269 | -$235 | -$291 |
| Net Acquisitions | $1,274 | -$940 | -$538 | -$1,792 |
| Inv. Purchases | -$7 | -$12 | -$10 | -$27 |
| Inv. Sales/Matur. | $3 | $7 | $32 | $39 |
| Other Inv. Act. | -$5,038 | $33 | $16 | $197 |
| Investing Cash Flow | -$3,264 | -$1,181 | -$735 | -$1,874 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,775 | $209 | $2,561 | -$3,762 |
| Stock Issued | -$977 | $0 | $0 | $0 |
| Stock Repurch. | $4 | -$12 | -$961 | -$358 |
| Dividends Paid | -$2,911 | -$2,910 | -$2,925 | -$2,752 |
| Other Fin. Act. | $1,069 | $3 | $67 | $11 |
| Financing Cash Flow | -$4,590 | -$2,710 | -$1,258 | -$6,861 |
| Forex Effect | -$8 | $30 | $9 | -$46 |
| Net Chg. in Cash | -$838 | $1,292 | -$349 | -$1,733 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,467 | $5,175 | $5,524 | $7,257 |
| End Cash | $5,629 | $6,467 | $5,175 | $5,524 |
| Free Cash Flow | $7,528 | $4,884 | $1,400 | $6,757 |